Mytos
ActiveRobotic human cell manufacturing
This company has previously operated under “HackScience”, “Cytera CellWorks”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
Mytos builds robots for manufacturing human cells. Operators input stem cells, and our platform turns them into specific cells such as neurons and heart cells over multiple weeks. Last year, patients were cured of Parkinson’s, vision loss, and Type 1 diabetes using stem-cell derived cells. We need 1000x the global capacity to produce these cells, and treat millions of patients. But today these Regenerative Medicines are produced by hand, meaning they’re too expensive and don’t scale. Mytos has fully automated production of these cells, making it scalable. We have our first manufacturing deal - neurons for treating Parkinson’s - and we’re in conversations with majority of the other top players.
Founders · 2
CEO and Co-Founder of Mytos. I'm a mixture between a scientist and an engineer, having solved challenges both using physics/chemistry, as well as through building hardware and software. I aspire to operate at the interface of science and engineering, where low level science translates into meaningful products.
Related startups
Democratizing gene therapy by reinventing its manufacturing and…
Enabling next generation medicines. A comprehensive platform and…
